Indeed, increased Src activity has been linked to the progression and malignancy of colorectal cancer, breast cancer, ovarian cancer, and lung carcinomas [54], as well as poor clinical prognosis and resistance to cancer therapy [55]. The gene discussed is SRC; the disease is ovarian carcinoma.